Clinical Trials Browser

GDC-0084 × Breast × 1 year × Clear all

NCT03765983 2026-05-27

GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases

Phase 2 Terminated

17 enrolled 14 charts

Breast Neoplasms